A modified technique to safely close the arterial puncture site after TAVI

Journal of Invasive Cardiology

Volumn 25, Issue 1, 2013, Pages 45-47

  Vavuranakis, Manolis ^a   Kalogeras, Konstantinos I ^a   Vrachatis, Dimitrios A ^a   Kariori, Maria G ^a   Aznaouridis, Konstantinos ^a   Moldovan, Carmen ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

TAVI; vascular complications

Indexed keywords

ARTERY CATHETERIZATION; ARTERY PUNCTURE; ARTICLE; BLEEDING; CARDIOVASCULAR PROCEDURE; CLINICAL PRACTICE; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATIENT SAFETY; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; VASCULAR CLOSURE;

AORTIC VALVE; CARDIAC CATHETERIZATION; FEMORAL ARTERY; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; ILIAC ARTERY; MORBIDITY; PUNCTURES;

EID: 84872303616     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hildick-Smith D, Redwood S, Mullen M, et al. Complications of transcatheter aortic valve implantation: avoidance and management. EuroIntervention. 2011;7(5):621-628.
2. Vavouranakis M, Vrachatis DA, Toutouzas K P, et al. "Bail out" procedures for malpo-sitioning of aortic valve prosthesis (CoreValve). Int J Cardiol. 2010;145(1):154-155.
3. Vavuranakis M, Vrachatis D, Stefanadis C. CoreValve aortic bioprosthesis: repositioning techniques. JACC Cardiovasc Interv. 2010;3(5):565; author reply, 565-566.
4. Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4(8):851-858.
5. Gonze MD, Sternbergh WC 3rd, Salartash K, Money SR. Complications associated with percutaneous closure devices. Am J Surg. 1999;178(3):209-211.
6. Van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcath-eter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention. 2010;5(6):673-679.
7. Tchetche D, Dumonteil N, Sauguet A, et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention. 2010;5(6):659-665.
8. Genereux P, Kodali S, Leon MB, et al. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv. 2011;4(8):861-867.
9. Buchanan GL, Chieffo A, Montorfano M, et al. A 'modifed crossover technique' for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2012 Apr 18. (Epub ahead of print).
10. Vavuranakis M, Voudris V, Vrachatis DA, et al. Transcatheter aortic valve implantation, patient selection process and procedure: two centres' experience of the intervention without general anaesthesia. Hellenic J Cardiol. 2010;51(6):492-500.
11. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint defnitions for transcath-eter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57(3):253-269.